comprehensive -WSS

comprehensive

author：hotspot 2025-10-01 22:48:31 - browse：29621

Jacob S. Van Naarden (left), Athena Countouriotis( center), and Vlad Coric (right) on stage at the 2023 STAT Summit. — From left, Eli Lilly's Jacob S. Van Naarden, Avenzo's Athena Countouriotis, and Biohaven's Vlad Coric on stage at the 2023 STAT Summit. STAT

What does it feel like to run a biotech startup and then get “the call” — the one from the big pharma CEO who wants to acquire your company for billions of dollars?

At the 2023 STAT Summit on Wednesday, senior biotech writer Adam Feuerstein posed this question to three people very qualified to answer it: Vlad Coric, chairman and CEO of Biohaven, which was acquired by Pfizer in 2022 for $11.6 billion; Jacob Van Naarden, former COO of Loxo Oncology, which was acquired by Eli Lilly (where Van Naarden is now executive vice president) for $8 billion in 2019; and Athena Countouriotis, whose company Turning Point Therapeutics was acquired by BMS for $4 billion in 2022.

“Imagine you’re going through your typical day, and you get a message: Albert Bourla, chairman and CEO of Pfizer, wants to talk at six o’clock tonight,” said Coric, whose company had a successful migraine drug on the market and had just completed an IPO at the time.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Wegovy leads to weight loss. Can it treat depression, too?

leisure time

WSS

Health Care Service Corp to buy Cigna Medicare Advantage plans

Pancreatic cancer early detection could be helped by AI

FTC sues over Novant Health acquisition of two N.C. hospitals

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

Reconstructing family trees of blood cells may help predict disease

Vertex non

hotspot

comprehensive

knowledge

Walensky prepares to leave CDC — and Congress — behind

Reconstructing family trees of blood cells may help predict disease

23andMe had bad news about my health. I wish a person had delivered it

New rules on organ donation and transplantation 'will bring chaos'

How to save PrEP access — and even expand it

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Merck CEO won’t testify in Senate, citing no expertise in drug prices

In Memoriam: Notable people who died in 2023

Health Care Service Corp to buy Cigna Medicare Advantage plans

focus

In new study, freeze

Biogen walks away from Aduhelm, years after polarizing approval

FDA official pushes for dedicated emerging pathogens team

Marvel Studios reveals new trailer for 'The Marvels': Watch here

Our daughter's deadly disease: trisomy 18. We wanted to protect her

Philips to halt sales of sleep apnea machines in U.S.

focus

leisure time

entertainment

leisure time